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Abstract
Background
Antimicrobial resistance (AMR) rates may display seasonal variation. However, it is not
clear whether this seasonality is influenced by the seasonal variation of infectious diseases,
geographical region or differences in antibiotic prescription patterns. Therefore, we
assessed the seasonality of AMR rates in respiratory bacteria.
Methods
Seven electronic databases (Embase.com, Medline Ovid, Cochrane CENTRAL, Web of
Science, Core Collection, Biosis Ovid, and Google Scholar), were searched for relevant
studies from inception to Jun 25th, 2019. Studies describing resistance rates of Streptococ-
cus pneumoniae and Haemophilus influenzae were included in this review. By using ran-
dom-effects meta-analysis, pooled odd ratios of seasonal AMR rates were calculated using
winter as the reference group. Pooled odd ratios were obtained by antibiotic class and geo-
graphical region.
Results
We included 13 studies, of which 7 were meta-analyzed. Few studies were done in H. influ-
enzae, thus this was not quantitively analyzed. AMR rates of S. pneumoniae to penicillins
were lower in other seasons than in winter with pooled OR = 0.71; 95% CI = 0.65–0.77; I2 =
0.0%, and to all antibiotics with pooled OR = 0.68; 95% CI = 0.60–0.76; I2 = 14.4%. Irrespec-
tive of geographical region, the seasonality of AMR rates in S. pneumoniae remained the
same.
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Conclusion
The seasonality of AMR rates could result from the seasonality of infectious diseases and
its accompanied antibiotic use.
Introduction
Globally, bacterial respiratory infections are a leading cause of morbidity and mortality. Strep-
tococcus pneumoniae and Haemophilus influenzae are a common cause of community-acquire
pneumoniae and meningitis in children worldwide [1]. In 2015, pneumonia killed 920,136
children under 5 years, and accounted for 16% of all deaths in this age group [2]. In the last
two decades, respiratory bacteria have increasingly becoming resistant to several antibiotics,
and the prevalence of resistant strains is growing rapidly. Between the 20% to 30% of all pneu-
monias are caused by multidrug-resistant S. pneumoniae [1], and about the 30% to 40% are
caused by penicillin-resistant S. pneumoniae [3–5]. Resistant infections lead to a longer stay in
hospital, higher health-care costs, and increased mortality [6, 7]. In 2017, the World Health
Organization (WHO) included S. pneumoniae and H. influenzae on the list of priority bacteria
for which new antibiotics are needed [8].
Emerging evidence suggests that AMR rates in respiratory bacteria show seasonal variation
as a results of a dynamic interaction between host and environment, and antibiotic selective
pressure; however, results are highly variable among studies. For instance, prescription rates of
penicillins, cephalosporins and macrolides increased by 75% and 100% in the winter compared
to summer [9], which was associated with winter-peaks of resistance in S. pneumoniae to peni-
cillins and cephalosporins [4, 10–12], whereas AMR rates to macrolides showed no seasonal
variation [13]. A study in the United States showed that the rates of penicillin-resistant S. pneu-
moniae were higher in spring than in winter [5], while other studies in Spain showed higher
resistance rates in both summer and winter [3, 13]. On the other hand, studies done in Israel
and Lituania reported higher resistance rates of multidrug-resistant S. pneumoniae in winter
than in summer [14, 15]. Furthermore, resistant rates of H. influenzae to penicillins and
macrolides tended to be higher in winter than in summer in a study done in Japan [16], while
another study from Italy did not find significant differences in resistance rates between
autumn and spring [17].
Although, the variability in the seasonality of AMR rates has been linked to seasonal varia-
tion of antibiotic consumption [18–20], other factors such as different patterns of antibiotic
use or geographical region may influence on the variation of AMR rates [9, 18]. In this era of
increasing trends of AMR, it is pivotal to understand all phenomena contributing to the selec-
tion of AMR. Thus, we summarized relevant published studies to assess the seasonality of
AMR rates in respiratory bacteria, and to identify factors underlying this pattern.
Materials and methods
This systematic review and meta-analysis follows the guidelines in the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement (S1 Table) [21].
Search strategy and selection criteria
The search strategy in this systemtaic review was originally established to find studies address-
ing the variation of AMR rates per month and/or per season in five bacteria included on the
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OMS priority bacteria list [8]: Campylobacter spp., Salmonella spp., Escherichia coli, Streptococ-
cus pneumoniae, and Haemophilus influenzae. However, we decided to focus only on respira-
toy bacteria, because studies in E. coli, Salmonella spp. and Campylobacter spp. where not
eligible for further analysis due to either few number of available studies or high heterogeneity
making it difficult to compare them.
Relevant studies were searched in seven electronic databases (Embase.com, Medline Ovid,
Cochrane CENTRAL, Web of Science, Core Collection, Biosis Ovid, and Google Scholar)
from inception until October 23rd, 2018, with an update until Jun 25th, 2019. The search terms
list is shown in the supporting information (S1 Text). Studies reporting AMR rates in respira-
tory bacteria from at least two different seasons were eligible for consideration. We included
studies that fulfilled the following inclusion criteria: 1) being cross-sectional, cohort, time-
series, and longitudinal studies in design; 2) describing bacteria isolates from humans; 3) mea-
suring antibiotic resistance as the study goal; 4) standard methods used for antibiotic suscepti-
bility testing; 5) primary outcome reported per month or season.
Study selection and quality assessment
Titles were retrieved from each electronic database and duplicates removed. The review of
retrieved studies was done based on the method of Bramer et al. [22]. Briefly, independently,
four authors (EPM, MG, MJ, JS) screened the title and abstracts of the retrieved references.
Selected references were full-text retrieved and assessed for inclusion eligibility independently
by two authors (EPM, MJ). A third author (MC) was available to discuss disagreements. For
additional studies, the reference lists of included studies were hand-searched and correspond-
ing authors of selected studies were contacted via e-mail.
As there is no single recommended tool for assessing the quality of cross-sectional studies,
we developed a modified version of the Newcastle-Ottawa Scale (NOS) for cohort and case-
control studies [23]. We used five quality criteria: 1) the representativeness of sample source;
2) the length of follow-up; 3) comparability of the population within the study period; 4) reli-
ability measure of antibiotic sensitivity; and 5) a clear description of the outcome (S2 Text).
Data extraction and analysis
Data was extracted from text, tables or graphs from each selected study; and was recorded in a
customized form for this systematic review. We extracted data regarding authors, year of pub-
lication, study location, and duration, study design, sample size, characteristics of the study
population and season definition. Also, we extracted the frequency or percentage of resistance
to any antibiotic class (including multi-resistance profiles) per season (or monthly) and per
bacterial species.
Studies were categorized according to the WHO regions definition as follows: Europe
(Spain, Israel, Lithuania, England, Italy and Norway), America (The United States and Costa
Rica), South East Asia (Thailand and India), and Western Pacific (Japan and Australia). Based
on the mechanism of action, antibiotics were categorized into the following classes: penicillins,
cephalosporins, macrolides, sulphamides and trimethoprim. Also, multidrug-resistance cate-
gorization was used to define isolates resistant to more than two antibiotic classes.
Meteorological seasons were defined as winter (December to February), summer (June to
August), autumn (September to October), and spring (March to May) for studies in the north-
ern hemisphere, whereas for studies in the southern hemisphere the definition of seasons was
opposite. For studies that present results with other season definitions such as: wet (December
to April) and dry (May to November), and as cold (October to March), and warm (April to
September) were not considered for quantitative analyses.
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For the quantitative analyses, we calculated for each study the seasonal resistance rates
according to antibiotic class and geographical region. For this calculation, we used as the
numerator the number of resistant isolates, and as the denominator, the total number of iso-
lates tested per season. monthly resistance rates per year were provided, in this case resistance
rates were pooled per month followed by season. In two studies [10, 11] the denominator was
not available and this was imputed assuming the best-case scenario where the sampling was
equally distributed across the length of the study. This assumption was based on the hypothesis
that the proportion of resistance isolates would vary according to the season independently of
the sample size. Thus, we calculated the denominator by dividing the overall number of iso-
lates tested by the number of seasons included in the study (e.g. dividing by four if the study
presented resistance rates in four seasons).
Secondly, we calculated separate seasonal resistance ratios according to antibiotic class
using winter as the reference group. In an extra analyses, we compared spring and autumn in
to include studies that only used these seasons, here spring was the reference group.
Finally, we carried out random-effects meta-analyses weighted by study size to calculate
pooled odds ratios (OR) and 95% confidence intervals for each comparison stratified by antibi-
otic class and geographical region. Heterogeneity across studies was measured using the I2 test.
We examined publication bias for each comparison by examining asymmetry funnel plots and
using Egger’s test. All tests were two-tailed and p-values < 0.05 were significant. Also, we per-
formed sensitivity analyses by doing extra meta-analysis estimating pooled OR excluding stud-
ies carried on in countries located in different hemispheres, and those studies in which the
denominator was imputed. All analyses were done using the statistical software STATA MP
14, and graphs were done in R 3.5.1 and R Studio 1.1.383.
Results
Description of included studies
We retrieved 3.851 unique references, of which 258 studies were full-text assessed, and 13 stud-
ies were included for the qualitative synthesis, of which seven were meta-analyzed (Fig 1). No
additional studies were identified by authors contact or hand-search nor after updating the lit-
erature search.
Most of the studies were cross-sectional (n = 7), performed in countries located in the
northern hemisphere (n = 10), and in European countries (n = 6). The majority of studies
were done for S. pneumoniae (n = 11), and on isolates from community-acquired infections in
children with acute otitis media (n = 9). The most common resistance profile studied was
against penicillins in S. pneumoniae isolates (n = 6) (Table 1).
Study quality
Quality assessment showed that most of included studies had fair quality (S2 Table). 11
(84.6%) studies were adjusted to control for confounders, and 12 (92.3%) studies used stan-
dard methods to measure the outcome of study. The common reason to score fair quality was
the study time period, six studies (46.2%) did not allow us to categorize the four metereological
seasons (S2 Table).
Seasonality of antimicrobial resistance rates
Only two studies reported seasonality of AMR rates in H. influenzae [16, 17], thus they were
not meta-analyzed. One study showed higher AMR rates to penicillins in spring than in
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autumn (10.1% vs 5.8%), whereas in the other study no significant differences in AMR rates to
ampicillin between summer and winter were found (18.5% vs 16.8%; P>0.05).
Three studies reported AMR rates in S. pneumoniae with different season categorizations:
wet vs dry [24], cold vs warm [14], and respiratory (i.e. winter and spring) vs non-respiratory
seasons (i.e. summer and autumn) [12], and therefore were not meta-analyzed. These studies
showed similar results as the meta-analyzed studies; higher AMR rates of penicillin-resistant
isolates in the wet, respiratory season, and cold months (S3 Table).
In the seven studies [3–5, 10, 11, 13, 15] used for the meta-analysis, AMR rates of S. pneu-
moniae were lower in other seasons than in winter (pooled OR = 0.71; 95% CI = 0.65–0.77;
I2 = 0.0%). AMR rates of S. pneumoniae to penicillins were also lower in other seasons than in
winter (pooled OR = 0.68. 95% CI = 0.60–0.76. I2 = 14.4%) [3–5, 10, 11, 13] (Fig 2).
A sensitivity analysis was done only by excluding the two studies where the denominador
was imputed, and the seasonal variation of AMR rates remained the same (S1 Fig). In
Fig 1. PRISMA flowchart summarizing the study selection process.
https://doi.org/10.1371/journal.pone.0221133.g001
Seasonality of antimicrobial resistance rates in respiratory bacteria: A systematic review
PLOS ONE | https://doi.org/10.1371/journal.pone.0221133 August 15, 2019 5 / 14
additional analyses, we did not find differences in AMR rates of S. pneumoniae between spring
and autumn independently of geographical region and antibiotic class (Fig 3). The description
of the study weights for each meta-analysis are present in the supporting information S4
Table.
We identified relatively low heterogeneity (I2<50%) among included studies, except in
comparisons between autumn and spring (I2>60%) (Figs 2 and 3). Based on observation of
funnel plots, there was no evidence of publication bias (S2 Fig). However, we identified larger
effect sizes of small-studies (Egger P<0.05) when comparing between summer and winter (S5
Table).
Discussion
In this study we describe the seasonality of AMR rates in two respiratory bacteria S. pneumo-
niae and H. influenzae. Few studies have been done in H. influenzae and no meta-analysis was
performed, but according to the available evidence AMR rates tended to be higher in winter
Table 1. General descriptive information of included studies (n = 13).
Reference Publication
year
Study type Country Hemisphere Study
region
Study period Sample source AMR
breakpoint
Season
definition
AMR
pattern
Streptococcus pneumoniae
Albanese et al.[12] 2002 Cross-
sectional
USA N AM Jan 1995 to Dec
1997
Patients with respiratory
infections
CSLI 2 PEN
Baquero et al. [13,
25]
1999 Prospective Spain N EU May 1996 to Apr
1997
Patients with respiratory
infections
CSLI 1 PEN
Boken et al. [25] 1995 Cross-
sectional
USA N AM April to August
1994
Children aged 2 to 24
months with respiratory
infections
CSLI 2 PEN
Dagan et al. [14] 2008 Prospective Israel N/E EU From 1998 to 2003 Children with acute otitis
media
CSLI 3 PEN, CEP,
MC, MDR
Guevara et al. [24] 2008 Cross-
sectional
Costa
Rica
N/W AM From 1994 to 2004 Children until 2 years with
otitis media
CSLI 4 PEN, MC
Hoberman et al.
[5]
2005 Cross-
sectional
USA N AM May 1991 to Apr
2003
Children 2 months to 7
years with respiratory
infection
CSLI 1 PEN, MC,
TM/SUL
Marco et al. [3] 2000 Cross-
sectional
Spain N EU May 1996 to Apr
1997
Patients with respiratory
infections
CSLI 1 PEN, CEP,
MC
Siripongpreeda
et al. [4]
2010 Retrospective Thailand N/E SEA Jan 1997 to Dec
2007
Patients aged <18 with
respiratory infection
CSLI 5 PEN
Stacevičiene et al.
[15]
2016 Prospective Lithuania N EU Feb 2012 to Mar
2013
Children aged <6 years
with respiratory infection
EUCAST 1 MDR
Tam et al. [10] 2015 Cross-
sectional
USA N AM From 2007 to 2012 Children aged < 5 years
with respiratory infection
N/A 1 PEN
Vardhan & Allen
[11]
2003 Prospective England N EU Jan 1987 to Dec
2000
Children with respiratory
infection
CSLI 1 PEN
Streptococcus pneumoniae and Haemophilus influenzae
Marchisio et al.
[17]
2001 Longitudinal Italy N EU Oct–Nov in 1996,
and Apr–May in
1997
Healthy children aged 1 to 7
years.
CSLI 2 PEN, MC
Haemophilus influenzae
Hashida et al. [16] 2008 Cross-
sectional
Japan N WP Jul 2004 to Feb
2005
Healthy children aged 1 to 6
years
CSLI 5 PEN
N = Northern hemisphere, N/W = Northern/Western Hemisphere and N/E = Northern/Eastern hemisphere. EU = Europe, SEA = South-East Asia, WP = Western
Pacific, and AM = Americas. 1 = Winter, Spring, Summer and Autumn, 2 = Spring vs Autumn, 3 = Cold vs Warm, 4 = Wet vs Dry, 5 = Winter vs Summer.
CSLI = Clinical Laboratory Standards Institute, EUCAST = European Committee on Antibiotic Susceptibility Testing. PEN = penicillins, CEP = Cephalosporines,
MC = Macrolides, SUL = Sulphamides, TM = Trimethoprim, and MDR = Multidrug-resistant. N/A = not available.
https://doi.org/10.1371/journal.pone.0221133.t001
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than summer. We found a consistent winter-peak of AMR rates in S. pneumoniae for penicillin
and other antibiotics (i.e. cephalosporins, macrolides) independently of the geographical
region.
The seasonal variation of AMR rates could results from a dynamic interaction of factors
closely related with the seasonality of the infectious diseases such as higher antibiotic con-
sumption [9, 18, 26], an increase of resistant strains during the peak of the infection [4, 12]. A
3-year population-based study in the USA, showed that the incidence rate of pneumococcal
disease varied from 10 cases per 100.000 population in summer to 35–70 cases per 100.000
population in winter [27]. It was suggested that differences in host susceptibility, environmen-
tal factors, population behavior, and interactions among pathogens are determinants for sea-
sonal incidence of pneumococcal infections [27–29]. For example, the winter-peak of
incidence rates of pneumonococcal infections was associated with photoperiod variation and
inversely correlated with temperature (i.e. increased number of hours of darkness with cold
temperatures)[27], which would results in a higher pathogen abundance in winter. Besides, it
was shown significant correlation between the winter-peak of respiratory syncytial virus and
penicillin-resistant S. pneumoniae peaking in the winter [29], and thus the potential interac-
tion with respiratory virus may actively participate in the winter seasonal peak of AMR rates.
Furthermore, seasonal variation in outpatient antibiotic use has been reported in Europe
and the United States. The total antibiotic use increase between 24% to 38% in the winter com-
pared with summer [9, 18, 26], mostly due to the increase of use of penicillins cephalosporins,
and macrolides, which are broadly used to treat respiratory infections [30]. Other studies
reported also high use amoxicillin, amoxicillin-clavulanic acid, and quinolones in winter to
treat upper respiratory infections [15]. This increase of antibiotic use in winter could lead to
periods of multidrug-resistant isoaltes peaking. Moreover, the high antibiotic prescription
rates in the winter have been found to be innapropiate, as also viral respiratory infections
ocurr at higher rates during winter [9, 31, 32]. In a population-based study in the United
States, it was shownthat acute respiratory infections (e.g. sinusitis, otitits media, pnuemoniae)
account for 211 prescriptions per 1000 person per year, of which 111 prescription were
Fig 2. Forest plot of seasonality of antimicrobial resistance rates in Streptococcus pneumoniae isolates. Studies
were stratified into two subgroups of antibiotics and estimates of effect are presented as pooled odds ratios (squares)
with 95% confidence intervals (lateral lines of squares). For comparison, winter and spring were the reference groups,
thus equal to one. Solid vertical line limits no difference between the two groups. I2 refers to percentage of
heterogeneity among studies. The “All antibiotics” subgroup includes penicillins, cephalosporins, macrolides,
trimethoprim/sulphamides and multi-drug resistance.
https://doi.org/10.1371/journal.pone.0221133.g002
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estimated to be inappropriate [32]. This overuse probably increases the selection of resistant
Fig 3. Forest plot of seasonality of antimicrobial resistance rates in Streptococcus pneumoniae by geographical region. Studies were
stratified into two subgroups of antibiotics and estimates of effect are presented as pooled odds ratios (squares) with 95% confidence intervals
(lateral lines of squares). For comparison, winter and spring were the reference groups, thus equal to one. Solid vertical line limits no difference
between the two groups. I2 refers to percentage of heterogeneity among studies. The “All antibiotics” group include penicillins, cephalosporins,
and Multi-drug resistance. Northern refers to studies in the Northern hemisphere; European refers to studies done in Europe.
https://doi.org/10.1371/journal.pone.0221133.g003
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bacteria, and harbors the risk of spread in the community due to indoor activities during win-
ter [28].
Although we did not analyze the seasonal variation of outpatient antibiotic use, it was previ-
ously observed that a reduction of the total amount of antibiotic use in summer correlated
with an overall reduction of MDR and single-drug resistance in S. pneumoniae isolates in the
same season [14]. Similarly, a significant reduction of penicillin-resistant S. pneumoniae from
53% to 7% was found after a marked reduction of antibiotic use over a 4-month period [25].
Apparently, AMR impose high fitness cost on S. pneumoniae isolates reducing the transmissi-
bility after antibiotic pressure is reduced [14]. Therefore, it may be expected that the reduction
of antibiotic use in winter and spring will reduce AMR in the community in the same season.
However, future studies are necessary to understand the seasonal and long-term impact of
decreasing antibiotic use on resistance selection.
We did not find seasonal differences in rates in S. pneumoniae according to geographical
region, despite that some studies show differences in choice of antibiotic class at various levels
of the healthcare system (e.g. primary and secondary care) across regions, and in the structure
of the pharmaceutical market across countries [9, 18]. Furthermore, within a country, socio-
cultural determinants and educational level can influence the patient demands and the procliv-
ity of medical doctors for prescribing antibiotics [33], leading to regional differences in pre-
scription patterns. Regional differences in outpatients antibiotic use were shown in Europe;
the Southern and Eastern regions showed a mean winter increase of antibiotic use of about
35%, whereas in Northern regions the use was 25% less in winter, compared to summer [18,
26].
We could not perfom a meta-analysis in H. influenzae; however, it can be argued that the
seasonality of AMR rates will be similar to that in S. pneumoniae. These two bacteria are nor-
mally part of the nasopharyngeal flora and, the incidence of H. influenzae infections occurs at
higher rates in winter and spring compared with summer and autumn [17].
Clinical implications
In clinical settings, and from a public health perspective, the present review suggests a need to
adress the seasonality of infectious diseases and its subsequent antibiotic use in winter. The
high use of certain types of antibiotics in winter warrants attention because of the possible co-
selection of resistance and further spread of MDR in clinically important bacteria. Thus, sev-
eral efforts may be implemented to optimize the use of antibiotics in a specific season.
First, increasing collaboration among physicians prescribing antibiotics may be fundamen-
tal to promote prudent antibiotic use by enhancing stewardship programs in primary care and
hospital settings. According to the United States Center for Disease Control and Prevention
(CDC), appropiate antibiotic stewardship should be properly structured considering the core
elements including commitment, implementation of polices and practices, tracking and
reporting antibiotic use and resistance, and educational programs to patients and clinicians
[34]. We believe that the seasonal variation of the incidence of infectious diseases should be
part of such programs to reduce it impact in the seasonality of AMR rates in the community.
Second, implementing educational programs regarding appropriate antibiotic use for
patients are necessary. Educational programs have proven to be effective in the reduction of
outpatient antibiotic use; for instance, a population-based study in France showed that an
intensive educational program helped to decrease the number of prescription and to change
the dose/duration of the treatment leading to a reduction of penicillin-resistant S. pneumoniae
carriage in children [35]. Such program should be carried out during the winter season for a
higher impact.
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Third, according to the WHO, the prevention strategies for infectious diseases are mainly
based on vaccination, access to non-contaminated water, sanitation and hygiene in homes,
school and health care facilities [36]. This needs to be addressed at the start of the winter sea-
son when people are crowding inside. Therefore, international support is necessary to imple-
ment programs and health campaings to increase the awareness of respiratory infections
burden. Indeed, in Germany a health campaings implemented in autumn and winter increased
vaccine uptake in elderly people and resulted ina decrease in number of pneumonias [37].
Finally, new strategies are needed at the start of the winter season to reduce the use of anti-
biotics among such as, implementation of treatment guidelines and appropriate use of diag-
nostic tests. For instance, in Turkey, a combination of respiratoy viral panel (Multiplex PCR
panel) and rapid detection of streptococcus antigen limited the use of antibioticis in clinical
settings [31]. In primary care, the implementation of point-of-care testing (POCT) of C-reac-
tive protein (CRP) and traning to improve communication skills among general practitioners
were effective to optimize antibiotic use use [38]. Recently, in the United Kindom, POCT
effectiveness was proved by observing a shift in the prescription pattern among general practi-
tioners to less prescribing of antibiotics [39].
Strengths and limitations
To our knowledge, this is the first comprehensive systematic review and meta-analysis
addressing the seasonality of AMR rates in respiraty bacteria and the possible factors underly-
ing this pattern. However, some limitations need to be acknowledged. Firstly, we could not
systematically examine the direct effect of the seasonal variation of antibiotic use and seasonal-
ity of infections diseases, because these factors were not examined in most included studies.
Secondly, the meta-analysis we have included two studies assuming equally distributed
sampling throughout the study period. This assumption could not be always true, it could be
also expected that more isolates are taken in peak-periods of the infection, thus more likely to
have peaks in resistance due to higher exposure to antibiotics. However, sensitivity analysis
was done comparing results with and without these studies and the seasonality of AMR rates
in S. pneumoniae remained the same.
Finally, we cannot completely rule out publication bias and its influence on our meta-analy-
sis, because most of the studies were performed in Europe. We could not included six studies
in our meta-analysis, because it was not possible to categorize the four seasons. Thus, the
potential variation that could occur in countries with a different climate conditions, seasonal
incidence of infections and antibiotic use could be underrepresented.
Conclusion
In this comprehensive systematic review, we found a consistent winter-peak seasonal variation
of AMR rates in S. pneumoniae to penicillin and to all antibiotics, independently of geographi-
cal region. Due to the few available studies, we could not perform a quantitative analysis of sea-
sonality of AMR in H. influenzae. The seasonality of AMR rates could result from the
seasonality of infectious diseases and the accompanying antibiotic use. Future studies are
required to better understand the factors underlying the seasonality of AMR rates such as the
seasonal variation of antibiotic use and its temporal association with antimicrobial resistance
in clinically important bacteria.
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